BioFire
BioFire Dx Receives First FDA Marketing Clearance for SARS-CoV-2 Respiratory Panel
The test is the first COVID-19 assay to transition from Emergency Use Authorization to a cleared regulatory status.
Some tests that detect multiple SARS-CoV-2 genes are serendipitously signaling new viral variants while still effectively detecting infections.
Roche Diagnostics, Beckman Coulter, BioMérieux, Mesa Biotech Receive FDA 510(k) Clearances in November
The BioFire Defense subsidiary of BioMérieux obtained clearance for its FilmArray Global Fever Panel External Control Kit, used with the FilmArray Global Fever Panel.
BioMérieux Coronavirus Test Gets FDA OK for Use With Pooled Samples
The test, developed by BioMérieux subsidiary BioFire Defense, first received Emergency Use Authorization from the US Food and Drug Administration in March.
Multiplex PCR Panels for Joint Infections on the Horizon
BioFire has submitted a 39-target test to the US Food and Drug Administration. OpGen also has a test in development.
Aug 23, 2018
Jul 18, 2018
BioMérieux Q2 Revenues Up 3 Percent
Apr 19, 2018
BioMérieux Q1 Revenues Up 3 Percent
Mar 12, 2018
Feb 5, 2018
Jul 19, 2017
Jan 26, 2017
Nov 18, 2016
Oct 20, 2016